MEG localization of language-specific cortex utilizing MR-FOCUSS
暂无分享,去创建一个
Andrew C Papanicolaou | Panagiotis G Simos | Eduardo M Castillo | A. Papanicolaou | P. Simos | E. Castillo
[1] L. Kao,et al. Ophthalmic features of idiopathic intracranial hypertension , 2003, Eye.
[2] N. Tepley,et al. MEG localization of language-specific cortex utilizing MR-FOCUSS , 2004, Neurology.
[3] W. Schaper,et al. Collateral Circulation , 1993, Springer US.
[4] E. Ryan,et al. Neuropsychiatric impact of hepatitis C on advanced HIV , 2004, Neurology.
[5] M. Berciano,et al. Fulminant Guillain–Barré Syndrome with universal inexcitability of peripheral nerves: A clinicopathological study , 1997, Muscle & nerve.
[6] G Zouridakis,et al. Language dominance determined by magnetic source imaging , 1999, Neurology.
[7] A. Papanicolaou,et al. Magnetocephalography: a noninvasive alternative to the Wada procedure. , 2004, Journal of neurosurgery.
[8] H. Bonkovsky,et al. Reduction of health‐related quality of life in chronic hepatitis C and improvement with interferon therapy , 1999, Hepatology.
[9] R. Egan,et al. Doxycycline and intracranial hypertension , 2004, Neurology.
[10] P. Puglia. Willisian collateralization , 2005, Neurology.
[11] S. Zeuzem,et al. 106 International, multicenter, randomized, controlled study for the treatment of patients with chronic hepatitis C and persistently normal ALT levels with peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (copegus®) , 2003 .
[12] M. Wall,et al. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. , 1987, Archives of neurology.
[13] D. Liebeskind. Collateral therapeutics for cerebral ischemia , 2004, Expert review of neurotherapeutics.
[14] R. Hughes,et al. Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection , 1995, Annals of neurology.
[15] Y. Matsushima,et al. Analysis of the angiographic findings in cases of childhood moyamoya disease , 2004, Neuroradiology.
[16] J. Berciano,et al. Guillain‐Barré syndrome in Cantabria, Spain. An epidemiological and clinical study , 1994, Acta neurologica Scandinavica.
[17] C. Nimsky,et al. Functional neuronavigation with magnetoencephalography: outcome in 50 patients with lesions around the motor cortex. , 1999, Journal of neurosurgery.
[18] Josep Maria Salanova Grau,et al. Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides , 1995, Annals of neurology.
[19] Santiago Fernández,et al. Spanish Language Mapping Using MEG: A Validation Study , 2002, NeuroImage.
[20] G Zouridakis,et al. Identification of language-specific brain activity using magnetoencephalography. , 1998, Journal of clinical and experimental neuropsychology.
[21] W. Schaper,et al. Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis) , 2004, Circulation research.
[22] N. Yuki,et al. Does Campylobacter jejuni infection elicit “demyelinating” Guillain–Barré syndrome? , 2004, Neurology.
[23] M. Willenbring,et al. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. , 2000, The American journal of psychiatry.
[24] M. Manns,et al. Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. , 2003, PharmacoEconomics.